Ren, Y., Liu, Z., Yue, Y., Weng, S., Jia, H., Li, J., . . . Zhang, G. Multi-omics analysis of epigenetic dysregulation reveals clinical heterogeneity and evaluates the immunotherapeutic potential of lung adenocarcinoma. KeAi Communications Co., Ltd.
Chicago Style (17th ed.) CitationRen, Yuqing, et al. Multi-omics Analysis of Epigenetic Dysregulation Reveals Clinical Heterogeneity and Evaluates the Immunotherapeutic Potential of Lung Adenocarcinoma. KeAi Communications Co., Ltd.
MLA (9th ed.) CitationRen, Yuqing, et al. Multi-omics Analysis of Epigenetic Dysregulation Reveals Clinical Heterogeneity and Evaluates the Immunotherapeutic Potential of Lung Adenocarcinoma. KeAi Communications Co., Ltd.
Warning: These citations may not always be 100% accurate.